Pediatric Oncology

Liver and Pancreas Tumors

Questions discussed in this category

How do you approach relapsed hepatocellular malignant neoplasm NOS after transplant in pediatric or AYA patients?

What would be your next line of treatment for disease control in a pediatric patient with metastatic hepatocellular carcinoma in partial response after multiple therapies?

The patient already received PLADO+sorafenib, Y90, and Atezolizumab/Bevacizumab complicated by recurrent episodes of bleeding from esophageal varices....

2 Answers available

How do you approach treatment of metastatic hepatocellular carcinoma in an adolescent?

Would you offer liver transplant in the setting of metastatic disease?

1 Answer available

How do you choose first or second-line systemic therapy for fibrolamellar hepatocellular carcinoma?

What are there most evidence-based options?

1 Answer available

Should we be utilizing prophylactic G-CSF in our patients with intermediate risk of febrile neutropenia due to the COVID-19 pandemic?

Are you placing more weight on patient risk factors such as age >65 or co-morbidities?

2 Answers available

Papers discussed in this category

Proceedings of the National Academy of Sciences of the United States of America, 2015-11-03

Transcriptomic characterization of fibrolamellar hepatocellular carcinoma.

Oncologist, 2020 Mar 10

Phase II Multicenter, Open-Label Study of Oral ENMD-2076 for the Treatment of Patients with Advanced Fibrolamellar Carcinoma.

Semin Diagn Pathol, 2016 Dec 23

Fibrolamellar carcinoma: A histologically unique tumor with unique molecular findings.

Pediatric Oncology

Liver and Pancreas Tumors

Questions discussed in this category

Papers discussed in this category

Related Topics in Pediatric Oncology